Farmers National Bank’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.34M | Buy |
83,303
+1,546
| +2% | +$41.2K | 0.52% | 48 |
|
|
2025
Q4 | $2.04M | Sell |
81,757
-6,967
| -8% | -$176K | 0.45% | 52 |
|
|
2025
Q3 | $2.26M | Sell |
88,724
-1,493
| -2% | -$36.9K | 0.54% | 45 |
|
|
2025
Q2 | $2.19M | Sell |
90,217
-1,527
| -2% | -$35.6K | 0.58% | 44 |
|
|
2025
Q1 | $2.32M | Buy |
91,744
+1,396
| +2% | +$36.5K | 0.66% | 44 |
|
|
2024
Q4 | $2.4M | Buy |
+90,348
| New | +$2.45M | 0.7% | 39 |
|
|
2024
Q2 | $2.87M | Sell |
102,472
-2,536
| -2% | -$69.8K | 0.86% | 36 |
|
|
2024
Q1 | $2.91M | Sell |
105,008
-8,923
| -8% | -$248K | 0.87% | 34 |
|
|
2023
Q4 | $3.28M | Sell |
113,931
-11,886
| -9% | -$359K | 1.05% | 30 |
|
|
2023
Q3 | $4.17M | Buy |
125,817
+1,372
| +1% | +$48.5K | 1.45% | 22 |
|
|
2023
Q2 | $4.56M | Sell |
124,445
-1,327
| -1% | -$51.7K | 1.56% | 20 |
|
|
2023
Q1 | $5.13M | Sell |
125,772
-701
| -0.6% | -$30.3K | 1.82% | 14 |
|
|
2022
Q4 | $6.48M | Sell |
126,473
-1,831
| -1% | -$87.8K | 2.31% | 11 |
|
|
2022
Q3 | $5.61M | Sell |
128,304
-1,551
| -1% | -$75.4K | 2.25% | 12 |
|
|
2022
Q2 | $6.81M | Sell |
129,855
-8,761
| -6% | -$446K | 2.59% | 8 |
|
|
2022
Q1 | $7.18M | Sell |
138,616
-521
| -0.4% | -$27K | 2.49% | 8 |
|
|
2021
Q4 | $8.22M | Sell |
139,137
-12,701
| -8% | -$629K | 2.72% | 8 |
|
|
2021
Q3 | $5.59M | Buy |
+151,838
| New | +$6.73M | 2.23% | 10 |
|
|
2021
Q2 | – | Sell |
-142,449
| Closed | -$5.16M | – | 97 |
|
|
2021
Q1 | $5.16M | Sell |
142,449
-9,389
| -6% | -$333K | 1.96% | 13 |
|
|
2020
Q4 | $5.59M | Buy |
+151,838
| New | +$5.57M | 2.23% | 10 |
|
|
2019
Q2 | $5.2M | Buy |
126,574
+3,738
| +3% | +$148K | 2.72% | 7 |
|
|
2019
Q1 | $4.95M | Buy |
+122,836
| New | +$4.92M | 2.69% | 7 |
|
|
2018
Q2 | $4.38M | Buy |
127,249
+5,302
| +4% | +$181K | 2.67% | 6 |
|
|
2018
Q1 | $4.11M | Sell |
121,947
-1,296
| -1% | -$44.6K | 2.54% | 7 |
|
|
2017
Q4 | $4.24M | Buy |
123,243
+4,292
| +4% | +$146K | 2.45% | 9 |
|
|
2017
Q3 | $4.03M | Buy |
118,951
+6,061
| +5% | +$195K | 2.44% | 9 |
|
|
2017
Q2 | $3.6M | Buy |
112,890
+3,533
| +3% | +$111K | 2.13% | 13 |
|
|
2017
Q1 | $3.51M | Sell |
109,357
-6,541
| -6% | -$206K | 2.05% | 14 |
|
|
2016
Q4 | $3.57M | Buy |
115,898
+6,541
| +6% | +$200K | 2.06% | 15 |
|
|
2016
Q3 | $3.51K | Buy |
109,357
+14,863
| +16% | +$497K | 1.06% | 15 |
|
|
2016
Q2 | $3.16M | Buy |
94,494
+3,015
| +3% | +$96.2K | 1.87% | 16 |
|
|
2016
Q1 | $2.57M | Buy |
91,479
+19,170
| +27% | +$548K | 1.7% | 20 |
|
|
2015
Q4 | $2.21M | Buy |
72,309
+2,035
| +3% | +$64K | 1.61% | 21 |
|
|
2015
Q3 | $2.09M | Sell |
70,274
-210
| -0.3% | -$6.73K | 1.66% | 23 |
|
|
2015
Q2 | $2.24M | Sell |
70,484
-363
| -0.5% | -$11.8K | 1.71% | 22 |
|
|
2015
Q1 | $2.39M | Buy |
70,847
+108
| +0.2% | +$3.43K | 1.81% | 21 |
|
|
2014
Q4 | $2.09M | Buy |
+70,739
| New | +$2.03M | 1.72% | 20 |
|
Other funds holding PFE
VCM
VPM
Farmers National Bank's PFE Position: Q1 2026 in Review
Farmers National Bank increased its Pfizer (PFE) stake by 1.9% in Q1 2026, buying an estimated $41.2K and bringing the position to 83,303 shares worth $2.34M. The position accounts for 0.52% of the portfolio, ranked #48.
Farmers National Bank first reported a position in PFE in Q4 2014 and has held it in 37 quarters since. The position peaked at $8.22M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Farmers National Bank held 83,303 shares of Pfizer worth $2.34M as of Q1 2026.
- Farmers National Bank bought 1,546 Pfizer shares in Q1 2026, an estimated $41.2K.
- Pfizer made up 0.52% of Farmers National Bank's portfolio in Q1 2026, its #48 holding.
- Farmers National Bank first reported a position in Pfizer in Q4 2014 and has held it in 37 quarters since.
- Farmers National Bank's Pfizer position peaked at $8.22M in Q4 2021.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Farmers National Bank's 13F filing for Q1 2026, filed 8 Jun 2026.